BRPI0406819B8 - - Google Patents
Info
- Publication number
- BRPI0406819B8 BRPI0406819B8 BRPI0406819A BRPI0406819B8 BR PI0406819 B8 BRPI0406819 B8 BR PI0406819B8 BR PI0406819 A BRPI0406819 A BR PI0406819A BR PI0406819 B8 BRPI0406819 B8 BR PI0406819B8
- Authority
- BR
- Brazil
- Prior art keywords
- aminated
- type
- pneumococcal capsular
- hpaec
- chromatogram
- Prior art date
Links
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000014914 Carrier Proteins Human genes 0.000 abstract 2
- 108010078791 Carrier Proteins Proteins 0.000 abstract 2
- 125000003172 aldehyde group Chemical group 0.000 abstract 2
- 238000005349 anion exchange Methods 0.000 abstract 2
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 2
- NTBYIQWZAVDRHA-KCDKBNATSA-N (2s,3s,4r,5s)-2-amino-3,4,5-trihydroxyhexanal Chemical compound C[C@H](O)[C@@H](O)[C@@H](O)[C@H](N)C=O NTBYIQWZAVDRHA-KCDKBNATSA-N 0.000 abstract 1
- TVTGZVYLUHVBAJ-UHFFFAOYSA-N UNPD122247 Natural products CC1OC(O)C(N)C(O)C1O TVTGZVYLUHVBAJ-UHFFFAOYSA-N 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 150000002772 monosaccharides Chemical class 0.000 abstract 1
- NTBYIQWZAVDRHA-ARQDHWQXSA-N pneumosamine Chemical compound C[C@@H](O)[C@H](O)[C@H](O)[C@H](N)C=O NTBYIQWZAVDRHA-ARQDHWQXSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR03/00488 | 2003-01-17 | ||
| FR0300488A FR2850106B1 (fr) | 2003-01-17 | 2003-01-17 | Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5 |
| PCT/FR2004/000089 WO2004067574A1 (fr) | 2003-01-17 | 2004-01-16 | Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0406819A BRPI0406819A (pt) | 2005-12-27 |
| BRPI0406819B1 BRPI0406819B1 (pt) | 2017-01-03 |
| BRPI0406819B8 true BRPI0406819B8 (enExample) | 2021-05-25 |
Family
ID=32605815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0406819-0A BRPI0406819B1 (pt) | 2003-01-17 | 2004-01-16 | Psycho-capacular polycarbonate of the type 5 pneumococo aminated at the level of the aldeed group completes, its conjungate, pharmaceutical composition the comprehension and its production process, as well as processes of production of a formula conjugate of ps-ch2-nh- ch 2 -nh-s ???????? - p. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7812006B2 (enExample) |
| EP (1) | EP1590373B1 (enExample) |
| KR (1) | KR101044437B1 (enExample) |
| AT (1) | ATE520718T1 (enExample) |
| AU (1) | AU2004207647B2 (enExample) |
| BR (1) | BRPI0406819B1 (enExample) |
| CA (1) | CA2512847C (enExample) |
| DK (1) | DK1590373T3 (enExample) |
| FR (1) | FR2850106B1 (enExample) |
| IL (1) | IL169689A0 (enExample) |
| MX (1) | MXPA05007533A (enExample) |
| NZ (1) | NZ541254A (enExample) |
| WO (1) | WO2004067574A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7527797B1 (en) | 2000-09-01 | 2009-05-05 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Vibrio cholerae 0139 conjugate vaccines |
| EP2425853A1 (en) * | 2005-04-08 | 2012-03-07 | Wyeth LLC | Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition |
| US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US8808707B1 (en) | 2006-05-08 | 2014-08-19 | Wyeth Llc | Pneumococcal dosing regimen |
| US9522382B2 (en) * | 2011-09-06 | 2016-12-20 | Biologistics Llc | Affinity/lectin chromatography methods |
| EP2755683B1 (en) * | 2011-09-14 | 2019-04-03 | GlaxoSmithKline Biologicals SA | Methods for making saccharide-protein glycoconjugates |
| US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| EP3303357B1 (en) * | 2015-06-08 | 2021-05-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Vaccines against streptococcus pneumoniae serotype 5 |
| MX2019007910A (es) | 2016-12-30 | 2019-12-05 | Sutrovax Inc | Conjugados de polipeptido-antigeno con aminoacidos no naturales. |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| WO2018156467A1 (en) * | 2017-02-24 | 2018-08-30 | Merck Sharp & Dohme Corp. | Methods for improving filterability of polysaccharide-protein conjugate reactions |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| BR112020011414B8 (pt) | 2017-12-06 | 2023-01-31 | Merck Sharp & Dohme | Composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae |
| EP3897705A2 (en) | 2018-12-19 | 2021-10-27 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| US20230405137A1 (en) * | 2020-11-10 | 2023-12-21 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| CN120607643B (zh) * | 2025-07-24 | 2026-05-12 | 江苏中慧元通生物科技股份有限公司 | 一种肺炎球菌单价多糖的纯化工艺 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902506A (en) * | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
| US4761283A (en) * | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
| US5153312A (en) * | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| FR2682388B1 (fr) * | 1991-10-10 | 1995-06-09 | Pasteur Merieux Serums Vacc | Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal. |
| JPH08511007A (ja) | 1993-06-09 | 1996-11-19 | コノート ラボラトリーズ リミテッド | タンデム合成ｈｉｖ−１ペプチド |
| FR2763244B1 (fr) * | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
| EP1035137A1 (en) * | 1999-03-12 | 2000-09-13 | Pasteur Merieux Serums Et Vaccins | Method for the reductive amination of polysaccharides |
| JP2002539273A (ja) | 1999-03-19 | 2002-11-19 | スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム | ワクチン |
-
2003
- 2003-01-17 FR FR0300488A patent/FR2850106B1/fr not_active Expired - Lifetime
-
2004
- 2004-01-15 US US10/758,142 patent/US7812006B2/en active Active
- 2004-01-16 WO PCT/FR2004/000089 patent/WO2004067574A1/fr not_active Ceased
- 2004-01-16 BR BRPI0406819-0A patent/BRPI0406819B1/pt active IP Right Grant
- 2004-01-16 MX MXPA05007533A patent/MXPA05007533A/es active IP Right Grant
- 2004-01-16 EP EP04702733A patent/EP1590373B1/fr not_active Expired - Lifetime
- 2004-01-16 KR KR1020057013266A patent/KR101044437B1/ko not_active Expired - Lifetime
- 2004-01-16 AU AU2004207647A patent/AU2004207647B2/en not_active Expired
- 2004-01-16 DK DK04702733.9T patent/DK1590373T3/da active
- 2004-01-16 CA CA2512847A patent/CA2512847C/en not_active Expired - Lifetime
- 2004-01-16 AT AT04702733T patent/ATE520718T1/de not_active IP Right Cessation
- 2004-01-16 NZ NZ541254A patent/NZ541254A/en not_active IP Right Cessation
-
2005
- 2005-07-14 IL IL169689A patent/IL169689A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0406819A (pt) | 2005-12-27 |
| KR101044437B1 (ko) | 2011-06-27 |
| WO2004067574A1 (fr) | 2004-08-12 |
| NZ541254A (en) | 2008-07-31 |
| CA2512847C (en) | 2012-08-21 |
| EP1590373B1 (fr) | 2011-08-17 |
| KR20050093838A (ko) | 2005-09-23 |
| US7812006B2 (en) | 2010-10-12 |
| AU2004207647B2 (en) | 2010-07-01 |
| IL169689A0 (en) | 2007-07-04 |
| FR2850106B1 (fr) | 2005-02-25 |
| CA2512847A1 (en) | 2004-08-12 |
| EP1590373A1 (fr) | 2005-11-02 |
| AU2004207647A1 (en) | 2004-08-12 |
| BRPI0406819B1 (pt) | 2017-01-03 |
| FR2850106A1 (fr) | 2004-07-23 |
| DK1590373T3 (da) | 2011-12-05 |
| ATE520718T1 (de) | 2011-09-15 |
| US20040170638A1 (en) | 2004-09-02 |
| MXPA05007533A (es) | 2005-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL169689A0 (en) | Conjugates obtained by reductive amination of serotype 5 pneumococcus capsular polysaccharide | |
| Schwartz et al. | Proteins containing reductively aminated disaccharides: synthesis and chemical characterization | |
| Lotan et al. | Purification of wheat germ agglutinin by affinity chromatography on a sepharose-bound N-acetylglucosamine derivative | |
| DE50309087D1 (enExample) | ||
| JP4566194B2 (ja) | タンパク質の誘導体化及び結合のためのシアル酸誘導体 | |
| PT951552E (pt) | Adn e prote?nas ou p?ptidos espec?ficos de bact?rias da esp?cie neisseria meningitidis, processos para a sua obten??o e suas aplica??es biol?gicas | |
| AU5812400A (en) | Carrier-drug conjugate | |
| WO2002050122A3 (en) | Means for the diagnosis and therapy of ctcl | |
| CN104710511B (zh) | 一种源于带鱼鱼肉蛋白的铁螯合肽及其制备方法和用途 | |
| MXPA04008077A (es) | Anticuerpos ant-a° y su uso. | |
| IL159388A0 (en) | Improved chelator conjugates | |
| ATE206871T1 (de) | Molkeprotein/polysaccharide gel, hergestellt durch hochdruckbehandlung | |
| AU2003242535A1 (en) | Improved polysaccharide and glycoconjugate vaccines | |
| GB2383041A (en) | Process for the preparation of gabapentin | |
| HU184736B (en) | Process for preparing anticarcinogenic immunoglobuline derivatives | |
| Fernandez-Santana et al. | Glycosides of Monoallyl Diethylene Glycol. A New type of Spacer group for Synthetic Oligosaccharides | |
| PT1165489E (pt) | Processo para a preparacao de gabapentina | |
| BR0213773A (pt) | Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina | |
| ZA200006648B (en) | Water meter. | |
| Chen et al. | Neoglycoproteins: preparation of noncovalent glycoproteins through high-affinity protein-(glycosyl) ligand complexes | |
| AU2347501A (en) | Trp-protein-related mtr1 protein and dna sequence coding therefor | |
| Woollard | T Residual Lãctose in Hydrolysed Whey Products using Cation-Exchange High Performance Liquid | |
| Roy et al. | Michael addition of poly-L-lysine to N-acryloylated sialosides. Syntheses of influenza A virus haemagglutinin inhibitor and group B meningococcal polysaccharide vaccinest | |
| Newman et al. | Immunochemical studies on blood groups: Immunochemical properties of B-active and non-B-active blood group substances from horse gastric mucosae and the relative size distributions of oligosaccharides liberated by base-borohydride | |
| Candiano et al. | Glycosylation of human albumin in diabetes mellitus II. Extensive in vitro modification by trioses and hexoses as revealed by isoelectric focusing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/01/2017, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/01/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |